Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US8017112B2 · kind B2 · utility
4Cited by
13References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2006 |
| Grant date | Sep 13, 2011 |
| Priority date | — |
| Expiry date | Aug 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.